The high prevalence of these tumours and their potential to transform towards malignancy as well as the loss of the SUZ12 gene included in the NF1 microdeletion region represent predisposing factors which increase the MPNST risk of patients with large NF1 deletions. Here, NF1 is linked to malignant peripheral nerve sheath tumor.